The Cancer Drug Parity Act is a legislative proposal aimed at ensuring that patients have equal access to oral and intravenous cancer treatments. This act mandates that insurance companies provide the same level of coverage for oral cancer medications as they do for intravenous or injected treatments. The initiative addresses the disparity in out-of-pocket costs, often making oral medications more accessible and affordable for patients.
